lunes, 14 de noviembre de 2022

Tocilizumab in patients with severe COVID-19: a retrospective cohort study - The Lancet Rheumatology

Tocilizumab in patients with severe COVID-19: a retrospective cohort study - The Lancet Rheumatology

No hay comentarios:

Publicar un comentario